Method and anorectal formulations for treating hemorrhoidal diseases

• US 20060034825A1
• Filed: 08/29/2003
• Published: 02/16/2006
• Est. Priority Date: 08/29/2003
• Status: Abandoned Application

• Current Assignee: Amershire Investment Corporation
• Original Assignee: Amershire Investment Corporation
• Inventors: Charron, Dan
• Application Number:
  US10/650,746
• Publication Number:
  US 20060034825A1
• Time in Patent Office: Days
• US Class Current: 424/125
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 33/44 Elemental carbon, e.g. charcoal, carbon black
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

A method and anorectal formulation for treating a hemorrhoidal disease in a patient suffering therefrom. The method comprises the local administration of a therapeutically effective amount of activated carbon to the anorectal region of a patient. The anorectal formulation comprises a therapeutically effective amount of activated carbon as an active agent. The formulation may include one or more pharmaceutically acceptable carriers with or without one or more additional active agents. Also disclosed are methods of making the anorectal formulation and kits for treating hemorrhoidal diseases.

Claims

1. A method of treating a hemorrhoidal disease in a patient suffering therefrom, said method comprising local administration of a therapeutically effective amount of activated carbon to the anorectal region of said patient.

2. A method according to claim 1, wherein said activated carbon is applied to the anorectal region of said patient for a period that allows adsorption by said activated carbon.

3. A method according to claim 2, wherein said activated carbon is applied to the anorectal region of said patient for a period of at least 2 hours.

4. A method according to claim 1, wherein said local administration includes intra-rectal administration.

5. A method according to claim 4, wherein said intra-rectal administration includes administration to the venous plexus of the anorectal region.

6. A method according to claim 5, wherein said administration to the venous plexus includes administration above the dentate line of the anorectal region.

7. A method according to claim 1, wherein said local administration includes intra-anal administration.

8. A method according to claim 7, wherein said intra-anal administration is below the dentate line of the anorectal region.

9. A method according to claim 1, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration.

10. A method according to claim 9, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

11. A method according to claim 1, wherein said activated carbon is in powdered form.

12. A method according to claim 11, wherein said activated carbon powder is of pharmacopoeia grade.

13. A method according to claim 1, wherein said activated carbon is administered in a mixture together with an ingredient selected from the group consisting of a pharmaceutically acceptable carrier, an additional active agent and a combination thereof.

14. A method according to claim 13, wherein said activated carbon is present in said mixture from about 1% to 99% w/w of said mixture and said ingredient is present from about 1% to about 99% w/w of said mixture.

15. A method according to claim 14, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration, said activated carbon trituration having a potency of 1×

.

16. A method according to claim 15, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

17. A method according to claim 13, wherein said activated carbon is present from about 10% to 99% w/w of said mixture and said ingredient is present from about 1% to about 90% w/w of said mixture.

18. A method according to claim 17, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration, said activated carbon trituration having a potency of 2×

.

19. A method according to claim 18, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

20. A method according to claim 13, wherein said carrier is selected from the group consisting of:

Acetone Sodium Bisulfite;

Alcohol, Almond Oil, aloe barbadensis extract, aloe barbadensis gel, Anhydrous Lanolin;

Ascorbyl Palmitate, Avocado Oil, Beeswax, Benzethonium Chloride, Benzoic Acid;

Benzophenone-4;

benzyl alcohol, Benzyl Benzoate, BHA, BHT, Calcium Phosphate Dibasic, canola oil, capryl/capramidopropyl betaine, Carboxymethylcellulose Sodium, Castor Oil, Cetyl Alcohol, Citric Acid, Cocoa Butter, Corn Oil, Cottonseed oil, Diazolidinyl Urea, Edetate Disodium;

Glycerin, Glyceryl Monooleate, Glyceryl Monostearate, Glyceryl Monostearate;

Glyceryl Oleate, Glyceryl Stearate, grain alcohol, hydrogenated vegetable oil, Hydroxyethylcellulose;

Kaolin, Lactose, Lanolin, Lanolin Alcohol, Light Mineral Oil, Magnesium Stearate, Methylparaben, Microcrystalline Wax, Mineral Oil, Olive, olive oil, palm fruit oil, palm, palm oil, Paraffin, PEG 12 Dilaurate, Peruvian Balsam, petrolatum, petroleum, Polyethylene Glycol 300, Polyethylene Wax, Polysorbate 80, Propyl Gallate;

Propylene Glycol, Propylparaben, Purified Water;

Shark Liver Oil;

Simethicone;

Sodium Benzoate, Sodium Citrate, Sodium Lauryl Sulfate, Sorbitan Sesquioleate, Soybean oil, Sucrose, starch, Stearyl Alcohol, Sweet Almond Oil, Thyme Oil, Tocopherol;

tocopheryl acetate, Trisodium EDTA, Vitamin E, Water, wax, White Petrolatum, White Wax, Xanthan Gum and a combination thereof.

21. A method according to claim 13, wherein said additional active agent is selected from the group consisting of Acidum Muriaticum (Hydrochloric Acid), Aesculus hippocastanum (Horse Chesnut), Alcloxa, Aluminum hydroxide gel, Arctium lappa, Benzocaine, Benzyl, Bryonia alba (White Bryony), Calamine, Calcarea Fluorica (Calcium Fluoride), Calcarea Phosphorica (Phosphate of Calcium), Calendula officinalis, Camphor, Cocoa butter, Cod liver oil, Collinsonia canadensis (Stone-Root), Dibucaine hydrochloride, Dibucaine, Dyclonine hydrochloride, Echinacea, Ephedrine sulfate, Epinephrine hydrochloride, Epinephrine, Ferrum Phosphoricum (Phosphate of Iron), Glycerin, Graphites (Black Lead), Hamamelis virginiana, Hard fat, Hydrastis Canadensis, Hypericum, Juniper tar, Kali carbonicum (Potassium Carbonate), Kali Phosphoricum (Phosphate of Potassium), Kaolin, Lanolin, Lidocaine, Lycopodium clavatum (Clubmoss), Lycopodium, Magnesia Phosphorica (Phosphate of Magnesium), Menthol, Millefolium (Yellow Dock), Mineral oil, Natrum Phosphoricum (Phosphate of Soda), Nitricum acidum (Nitric Acid), Nux vomica (Quaker Button), Paeonia officinalis (Peony), Paeonia officinalis, Petrolatum, Phenylephrine hydrochloride, Plantago, Pramoxine hydrochloride, Quercus, Ratanhia, Resorcinol, Resorcinum, Shark liver oil, Solidago, Sulphur (Sublimed Sulphur), Tetracaine hydrochloride, Tetracaine, Topical starch, Urtica urens, Viburnum Opulus, White petrolatum, Witch hazel, Zinc oxide and a combination thereof.

22. An anorectal formulation for treating a hemorrhoidal disease in a patient in need thereof, said formulation comprising a therapeutically effective amount of activated carbon as the active agent.

23. An anorectal formulation according to claim 22, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration.

24. An anorectal formulation according to claim 23, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

25. An anorectal formulation according to claim 22, wherein said activated carbon is in powdered form.

26. An anorectal formulation according to claim 25, wherein said activated carbon powder is of pharmacopoeia grade.

27. An anorectal formulation according to claim 22 further comprising an ingredient selected from the group consisting of a pharmaceutically acceptable carrier, an additional active agent and a combination thereof.

28. An anorectal formulation according to claim 27, wherein said activated carbon is present from about 1% to 99% w/w of said formulation and said ingredient is present from about 1% to about 99% w/w of said formulation.

29. An anorectal formulation according to claim 28, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration, said activated carbon trituration having a potency of 1×

.

30. An anorectal formulation according to claim 29, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

31. An anorectal formulation according to claim 27, wherein said activated carbon is present from about 10% to 99% w/w of said formulation and said ingredient is present from about 1% to about 90% w/w of said formulation.

32. An anorectal formulation according to claim 31, wherein said activated carbon is triturated with a diluent to form an activated carbon trituration, said activated carbon trituration having a potency of 2×

.

33. An anorectal formulation according to claim 32, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

34. An anorectal formulation according to claim 27, wherein said carrier is selected from the group consisting of:

Acetone Sodium Bisulfite;

Alcohol, Almond Oil, aloe barbadensis extract, aloe barbadensis gel, Anhydrous Lanolin;

Ascorbyl Palmitate, Avocado Oil, Beeswax, Benzethonium Chloride, Benzoic Acid;

Benzophenone-4;

benzyl alcohol, Benzyl Benzoate, BHA, BHT, Calcium Phosphate Dibasic, canola oil, capryi/capramidopropyl betaine, Carboxymethylcellulose Sodium Castor Oil, Cetyl Alcohol, Citric Acid, Cocoa Butter, Corn Oil Cottonseed oil, Diazolidinyl Urea, Edetate Disodium;

Glycerin, Glyceryl Monooleate, Glyceryl Monostearate, Glyceryl Monostearate;

Glyceryl Oleate, Glyceryl Stearate, grain alcohol, hydrogenated vegetable oil, Hydroxyethylcellulose;

Kaolin, Lactose, Lanolin, Lanolin Alcohol, Light Mineral Oil, Magnesium Stearate, Methylparaben, Microcrystalline Wax, Mineral Oil, Olive, olive oil, palm fruit oil, palm, palm oil, Paraffin, PEG 12 Dilaurate Peruvian Balsam, petrolatum, petroleum, Polyethylene Glycol 300, Polyethylene Wax, Polysorbate 80, Propyl Gallate;

Propylene Glycol, Propylparaben, Purified Water;

Shark Liver Oil;

Simethicone;

Sodium Benzoate, Sodium Citrate, Sodium Lauryl Sulfate, Sorbitan Sesquioleate, Soybean oil, Sucrose, starch, Stearyl Alcohol Sweet Almond Oil, Thyme Oil, Tocopherol;

tocopheryl acetate, Trisodium EDTA, Vitamin E, Water, wax, White Petrolatum, White Wax, Xanthan Gum and a combination thereof.

35. An anorectal formulation according to claim 27, wherein said additional active agent is selected from the group consisting of:

Acidum Muriaticum (Hydrochloric Acid), Aesculus hippocastanum (Horse Chesnut), Alcloxa, Aluminum hydroxide gel, Arctium lappa, Benzocaine, Benzyl, Bryonia alba (White Bryony), Calamine, Calcarea Fluorica (Calcium Fluoride), Calcarea Phosphorica (Phosphate of Calcium), Calendula officinalis, Camphor, Cocoa butter, Cod liver oil, Collinsonia canadensis (Stone-Root), Dibucaine hydrochloride, Dibucaine, Dyclonine hydrochloride, Echinacea, Ephedrine sulfate, Epinephrine hydrochloride, Epinephrine, Ferrum Phosphoricum (Phosphate of Iron), Glycerin, Graphites (Black Lead), Hamamelis virginiana, Hard fat, Hydrastis Canadensis, Hypericum, Juniper tar, Kali carbonicum (Potassium Carbonate), Kali Phosphoricum (Phosphate of Potassium), Kaolin, Lanolin, Lidocaine, Lycopodium clavatum (Clubmoss), Lycopodium, Magnesia Phosphorica (Phosphate of Magnesium), Menthol, Millefolium (Yellow Dock), Mineral oil, Natrum Phosphoricum (Phosphate of Soda), Nitricum acidum (Nitric Acid), Nux vomica (Quaker Button), Paeonia officinalis (Peony), Paeonia officinalis, Petrolatum, Phenylephrine hydrochloride, Plantago, Pramoxine hydrochloride, Quercus, Ratanhia, Resorcinol, Resorcinum, Shark liver oil, Solidago, Sulphur (Sublimed Sulphur), Tetracaine hydrochloride, Tetracaine, Topical starch, Urtica urens, Viburnum Opulus, White petrolatum, Witch hazel, Zinc oxide and a combination thereof.

36. An anorectal formulation according to claim 22 in a form selected from the group consisting of a preparation, a suppository, a pad and a combination thereof.

37. An anorectal formulation according to claim 36, wherein said preparation is selected from the group consisting of:

a cream, an ointment, a lotion, a balm, a salve, an emollient, a liniment, an unguent, a demulcent, a cerate, a foam, a liquid, a viscous liquid, a powder and a combination thereof.

38. A method of preparing an anorectal formulation for treating a hemorrhoidal disease in a patient in need thereof, said method comprising providing a therapeutically effective amount of activated carbon.

39. A method according to claim 38, wherein said providing includes triturating activated carbon with a diluent

40. A method according to claim 39, wherein said diluent is selected from the group consisting of:

lactose and sucrose.

41. A method according to claim 39, wherein said activated carbon trituration has a potency of 1×

.

42. A method according to claim 39, wherein said activated carbon trituration has a potency of 2×

.

43. A method according to claim 38 further comprising mixing said activated carbon with an ingredient selected from the group consisting of a pharmaceutically acceptable carrier, an active agent and a combination thereof.

44. A method according to claim 43, wherein said activated carbon is present in said mixture from about 1% to 99% w/w of said mixture and said ingredient is present from about 1% to about 99% w/w of said mixture.

45. A method according to claim 43, wherein said carrier is selected from the group consisting of:

Acetone Sodium Bisulfite;

Alcohol, Almond Oil, aloe barbadensis extract, aloe barbadensis gel, Anhydrous Lanolin;

Ascorbyl Palmitate, Avocado Oil, Beeswax, Benzethonium Chloride, Benzoic Acid;

Benzophenone4;

benzyl alcohol, Benzyl Benzoate, BHA, BHT, Calcium Phosphate Dibasic, canola oil, capryi/capramidopropyl betaine, Carboxymethylcellulose Sodium Castor Oil, Cetyl Alcohol, Citric Acid, Cocoa Butter, Corn Oil Cottonseed oil, Diazolidinyl Urea, Edetate Disodium;

Glycerin, Glyceryl Monooleate, Glyceryl Monostearate, Glyceryl Monostearate;

Glyceryl Oleate, Glyceryl Stearate, grain alcohol, hydrogenated vegetable oil, Hydroxyethylcellulose;

Kaolin, Lactose, Lanolin, Lanolin Alcohol, Light Mineral Oil, Magnesium Stearate, Methylparaben, Microcrystalline Wax, Mineral Oil, Olive, olive oil, palm fruit oil, palm, palm oil, Paraffin, PEG 12 Dilaurate, Peruvian Balsam, petrolatum, petroleum, Polyethylene Glycol 300, Polyethylene Wax, Polysorbate 80, Propyl Gallate;

Propylene Glycol, Propylparaben, Purified Water;

Shark Liver Oil;

Simethicone;

Sodium Benzoate, Sodium Citrate, Sodium Lauryl Sulfate, Sorbitan Sesquioleate, Soybean oil, Sucrose, starch, Stearyl Alcohol Sweet Almond Oil, Thyme Oil, Tocopherol;

tocopheryl acetate, Trisodium EDTA, Vitamin E, Water, wax, White Petrolatum, White Wax, Xanthan Gum and a combination thereof.

46. A method according to claim 43, wherein said additional active agent is selected from the group consisting of:

Acidum Muriaticum (Hydrochloric Acid), Aesculus hippocastanum (Horse Chesnut), Alcloxa, Aluminum hydroxide gel, Arctium lappa, Benzocaine, Benzyl, Bryonia alba (White Bryony), Calamine, Calcarea Fluorica (Calcium Fluoride), Calcarea Phosphorica (Phosphate of Calcium), Calendula officinalis, Camphor, Cocoa butter, Cod liver oil, Collinsonia canadensis (Stone-Root), Dibucaine hydrochloride, Dibucaine, Dyclonine hydrochloride, Echinacea, Ephedrine sulfate, Epinephrine hydrochloride, Epinephrine, Ferrum Phosphoricum (Phosphate of Iron), Glycerin, Graphites (Black Lead), Hamamelis virginiana, Hard fat, Hydrastis Canadensis, Hypericum, Juniper tar, Kali carbonicum (Potassium Carbonate), Kali Phosphoricum (Phosphate of Potassium), Kaolin, Lanolin, Lidocaine, Lycopodium clavatum (Clubmoss), Lycopodium, Magnesia Phosphorica (Phosphate of Magnesium), Menthol, Millefolium (Yellow Dock), Mineral oil, Natrum Phosphoricum (Phosphate of Soda), Nitricum acidum (Nitric Acid), Nux vomica (Quaker Button), Paeonia officinalis (Peony), Paeonia officinalis, Petrolatum, Phenylephrine hydrochloride, Plantago, Pramoxine hydrochloride, Quercus, Ratanhia, Resorcinol, Resorcinum, Shark liver oil, Solidago, Sulphur (Sublimed Sulphur), Tetracaine hydrochloride, Tetracaine, Topical starch, Urtica urens, Viburnum Opulus, White petrolatum, Witch hazel, Zinc oxide a combination thereof.

47. A kit for treating a hemorrhoidal disease in a patient in need thereof, said kit comprising:

a support for an anorectal formulation including a therapeutically effective amount of activated carbon as the active agent; and

an applicator for applying said activated carbon to the anorectal region of said patient.

48. A kit according to claim 47, wherein said support is selected from the group consisting of:

a container, a capsule, a bottle, a jar, a can, a canister, a package, a packet and a tube.

49. A kit according to claim 47, wherein said activated carbon applicator is selected from the group consisting of:

a pipe, a tube, a syringe, a conduit, a hose, a swab, or a longitudinal insert member.

50. A kit according to claim 47, wherein said activated carbon applicator includes a delivery device for delivering said activated carbon from said support to the anorectal region when said applicator is at the anorectal region of said patient.

51. A kit according to claim 50, wherein said delivery device is selected from the group consisting of:

a pump and a spray.